siRNA treatment lowers triglycerides in patients with unusual problem
.STUDY FEATURE.19 September 2024.
Plozasiran decreased triglyceride amounts through 80% and also decreased the danger of pancreatitis in individuals with relentless chylomicronemia, along with or without a genetic diagnosis.